Skip to Content

BEACH 1112 (Uroqid-acid methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg)

Pill imprint BEACH 1112 has been identified as Uroqid-acid methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg.

and belongs to the drug class urinary anti-infectives. Risk cannot be ruled out during pregnancy. Methenamine/sodium acid phosphate methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Uroqid-acid methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg BEACH 1112
Discount Card Promo
Uroqid-acid
Imprint:
BEACH 1112
Strength:
methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Urinary anti-infectives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Beach Pharmaceuticals

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide